On 12 September 2025, Hoffmann-La Roche conducted a study is to assess the efficacy, safety, and pharmacokinetics ...

CarMax reports that the Chevrolet Traverse excels in space and tech, while the Honda Pilot offers superior driving experience ...

Travere Therapeutics, Inc. is rated Buy with FILSPARI’s robust growth, FDA approval, and key milestones ahead. Click here to ...

Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.

Today, the American Kidney Fund (AKF) and the IgA Nephropathy Foundation, joined by more than 50 advocates living with rare kidney diseases, are convening on Capitol Hill to rally support for policy ...

Stocks Crushing the Market, 6 Climb to Fresh Highs. Travere Therapeutics, Inc. (NASDAQ:TVTX) is one of the top performers on ...

Learn more about whether ADMA Biologics, Inc. or Travere Therapeutics, Inc. is a better investment based on AAII's A+ ...

Learn more about whether Alvotech or Travere Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, ...

Travere (TVTX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

Travere Therapeutics (TVTX) has witnessed significant developments, including the FDA's decision not to call an advisory committee meeting for the sNDA of FILSPARI®, while the drug is still under ...

Travere Therapeutics, Inc. (TVTX) shares are trading higher on Wednesday after the company announced that it was informed by ...